Software

Gyno

The online platform that simplifies and accelerates testing for the mutational status of the BRCA1, BRCA2, HRD, MMR, and MSI genes in gynaecological oncology.

CLIENTE: GSK

GYNO streamlines the management between the various stakeholders involved in the analysis of BRCA1, BRCA2, HRD, MMR, and MSI gene tests.

GYNO is a web platform that facilitates access to and management of bio-molecular diagnostic tests in the field of gynaecological oncology.

How it works?

GYNO efficiently manages the flow of information related to bio-molecular tests in order to outline personalised therapies for the treatment of specific types of cancer.

Through a Hub-Spoke model, the platform allows Italian oncology centres to connect with highly qualified molecular diagnostic laboratories, enabling clinicians from all healthcare facilities authorised for the treatment of ovarian and/or endometrial cancer to easily and directly request testing for the mutational status of BRCA1, BRCA2, HRD, MMR, and MSI genes. In particular, the solution efficiently manages the flow of information related to bio-molecular tests to define personalised therapies for the treatment of specific cancer types. The connection between key stakeholders involved in these tests (oncologists, pathologists, and specialised diagnostic laboratories) ensures the efficient management of diagnostic timelines, enabling timely initiation of the therapeutic process. The platform also provides specialised logistical support to optimise the transport process and track the journey of biological samples between the different involved structures.

BENEFITS

Simplifies test requests from the Spoke centre to the Hub laboratory

Manages the collection and delivery of biological samples

Ensures compliance of clinical data with privacy and security regulations

Provides clear and easily accessible results

<< Back to projects